In a clinically independent HCC cohort, we found that PRP19 was negatively correlated with DDX5 and B cell infiltration, and high PRP19 expression and attenuated DDX5 expression were associated with poor prognosis in patients with HCC. The gene discussed is DDX5; the disease is hepatocellular carcinoma.